UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported):
September 25, 2007
XCORPOREAL,
INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
001-31608
|
|
98-0349685
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification Number)
|
11150
Santa Monica Boulevard, Suite 340, Los Angeles, California
90025
(Address
of principal executive offices, including zip code)
(310) 424-5668
(Registrant’s
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2 below):
o
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.24d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.23e-4(c))
Item 7.01
Regulation FD Disclosure
Xcorporeal,
Inc. will present at The UBS 2007 Global Life Sciences Conference in New York
City on Tuesday, September 25th, 2007 at 8:00 am Eastern time. A copy of the
written materials for the presentation is furnished as Exhibit 99.1
hereto.
Unless
otherwise required by law, we disclaim any obligation to release publicly any
updates or changes in our expectations or any change in events, conditions,
or
circumstances on which any forward-looking statements are based.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
99.1 The
UBS
2007 Global Life Sciences Conference presentation
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned duly
authorized.
| |
|
|
| |
XCORPOREAL,
INC. |
|
|
|
| Date: September
25, 2007 |
By: |
/s/ Winson
W.
Tang |
| |
Winson
W. Tang |
| |
Chief
Operating Officer |